Brand Performance Insights from AplusA's Multiple Myeloma Tracker
hemato-oncology, Tracking Studies, Syndicated Studies, Oncology
Posts about
hemato-oncology (4)
Key Insights from a Multiple Myeloma Tracker
hemato-oncology, Tracking Studies, Syndicated Studies, Oncology
A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...
Who Are The Key Hemato-Oncology Market Stakeholders?
Healthcare Industry, hemato-oncology, Oncology
As a marketing professional in the healthcare industry, you need to accurately identify the...
Who are the Digital Opinion Leaders in Hemato-Oncology?
Healthcare Industry, Digital, hemato-oncology
KOLs (Key Opinion Leaders) have long since played an important and influential role in the...
5 Benefits of Syndicated Research in the Hematology Oncology Market
Healthcare Industry, Market Research Industry, hemato-oncology, Syndicated Studies
In the rapidly evolving
DLBCL Treatment: A Quick Overview
hemato-oncology, DLBCL market, Syndicated Studies, Oncology
DLBCL is the most common form of non-Hodgkin’s lymphoma (NHL), constituting 30% to 58% of lymphoma...
Why is the Hemato-Oncology Market Complex for Market Researchers?
hemato-oncology, Tracking Studies, Syndicated Studies, Oncology
The hematology oncology market is one of the most rapidly developing, with over sixty oncology...
Chronic Lymphocytic Leukemia: Current and Future CLL Treatments
hemato-oncology, Tracking Studies, Syndicated Studies, Oncology
Chronic Lymphocytic Leukemia is the most common form of leukemia in Western countries. Although...
Blood Cancer Treatments: Current and Future
Therapeutic Areas, hemato-oncology, Syndicated Studies, Oncology
Despite being considered as rare diseases, blood cancers account for 8% of all cancers and mainly...